Diacerein
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 4,5-diacetyloxy-9,10-dioxo-anthracene-2- carboxylic acid |
|
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | Lacking information |
| Legal status | ? |
| Routes | Oral |
| Pharmacokinetic data | |
| Protein binding | 99% |
| Metabolism | Hepatic: deacetylation to rhein, later glucuronidation and sulfate conjugation |
| Half-life | 4 to 5 hours |
| Excretion | Renal (30%) |
| Identifiers | |
| CAS number | 13739-02-1  |
| ATC code | M01AX21 |
| PubChem | CID 26248 |
| ChemSpider | 24456 |
| UNII | 4HU6J11EL5 |
| KEGG | D07270 |
| ChEMBL | CHEMBL41286 |
| Synonyms | Diacetylrhein; Diacerhein; 2-Anthracenecarboxylic acid, 4,5-bis(acetyloxy)-9,10-dihydro-9,10-dioxo-; 2-Anthroic acid, 9,10-dihydro-4,5-dihydroxy-9,10-dioxo-, diacetate; 9,10-Dihydro-4,5-dihydroxy-9,10-dioxo-2-anthroic acid, diacetate |
| Chemical data | |
| Formula | C19H12O8 |
| Mol. mass | 368.294 g/mol |
|
|
|
|
 (what is this?) (verify) |
|
Diacerein (INN), also known as diacetylrhein, is a drug used in the treatment of osteoarthritis.[1] It works by inhibiting interleukin-1. A 2005 Cochrane review found diacerein to be slightly, but significantly, more effective than placebo in improving pain and slowing the progress of osteoarthritis in the hip.[2]
Contents |
Side effects [edit]
The most common side effects of diacerein treatment are gastrointestinal, such as diarrhea.[2][3] Another side effect of diacerein is that the medicine changes the color of urine.[citation needed]
Dosage [edit]
The dosage of diacerein is 50 mg twice daily, after meals, for 3 or more years.[citation needed]
Marketing [edit]
It is marketed in Egypt and the Middle East by Evapharma.[4] The Original product company was TRB Ltd Swiss. In Pakistan, it is marketed and sold as Diora (Getz Pharma). In Greece it has been sold since 2001 by Faran Ltd under the trade name Verboril.[5]
See also [edit]
References [edit]
- ^ Harry Gouvas: Use of Sodium Hyaluronate in the treatment of Osteoarthritis, Greece, 2011
- ^ a b Fidelix TS, Soares BG, Trevisani VF (2006). "Diacerein for osteoarthritis". In Fidelix, Tania S.A. Cochrane database of systematic reviews (Online) (1): CD005117. doi:10.1002/14651858.CD005117.pub2. PMID 16437519. Free summary
- ^ (French) "Diacereine". BIAM. 1999-03-24. Retrieved 2007-06-13.
- ^ http://www.evapharma.com/products/Diacerein-Cap/
- ^ Faran AE, Brochure of Diacerein (VERBORIL), 2001
|
||||||||||||||||||||||||||||||||||
